We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
+31.63%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
10 Year Est. Return
AUM
$91M
AUM Growth
+$13.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
98.57%
Holding
11
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.2B
$50.5M 55.55%
6,164,548
IVVD icon
2
Invivyd
IVVD
$218M
$9.43M 10.37%
9,248,250
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$394M
$7.12M 7.83%
385,680
GUTS icon
4
Fractyl Health
GUTS
$111M
$4.7M 5.16%
1,856,117
TGTX icon
5
TG Therapeutics
TGTX
$7.62B
$3.78M 4.15%
161,600
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$3.54M 3.89%
110,400
SLN
7
Silence Therapeutics
SLN
$564M
$3.37M 3.7%
185,100
BBIO icon
8
BridgeBio Pharma
BBIO
$16.5B
$3.09M 3.39%
121,200
CRIS icon
9
Curis
CRIS
$7.83M
$2.27M 2.5%
21,098
PRQR icon
10
ProQR Therapeutics
PRQR
$265M
$1.86M 2.04%
1,019,498
ARWR icon
11
Arrowhead Research
ARWR
$12.4B
$1.31M 1.43%
67,400

Similar funds

M28 Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, M28 Capital Management held 11 positions worth $91M, up 18% from $77.1M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. M28 Capital Management opened no new positions and made no exits, leaving the 11-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • M28 Capital Management's ten largest holdings make up 99% of its $91M portfolio in Q3 2024.
  • M28 Capital Management opened 0 new positions and closed 0 in Q3 2024.
  • M28 Capital Management's portfolio value rose 18% quarter-over-quarter to $91M.

Based on M28 Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.